SHEL.UK

3,068.5

+0.1%↑

BP

513.5

-0.17%↓

DCC

6,200

+0.9%↑

SHEL.UK

3,068.5

+0.1%↑

BP

513.5

-0.17%↓

DCC

6,200

+0.9%↑

SHEL.UK

3,068.5

+0.1%↑

BP

513.5

-0.17%↓

DCC

6,200

+0.9%↑

SHEL.UK

3,068.5

+0.1%↑

BP

513.5

-0.17%↓

DCC

6,200

+0.9%↑

SHEL.UK

3,068.5

+0.1%↑

BP

513.5

-0.17%↓

DCC

6,200

+0.9%↑

Search

Smith & Nephew PLC

Nyitva

1,134 -0.18

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

1132.5

Maximum

1143

Fő mutatók

By Trading Economics

Bevétel

47M

342M

Értékesítés

318M

3.3B

P/E

Szektor átlag

21.306

63.807

Egy részvényre jutó nyereség

0.429

Osztalékhozam

3.43

Profit margin

10.36

Munkavállalók

16,988

EBITDA

162M

886M

Ajánlások

By TipRanks

Ajánlások

Vétel

12 hónapos előrejelzés

+23.96% upside

Osztalékok

By Acuity

Osztalékhozam

Szektor átlag

3.43%

3.59%

Következő eredményjelentés

2026. aug. 4.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

-1.4B

9.8B

Előző nyitás

1134.18

Előző zárás

1134

Smith & Nephew PLC Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Rólunk Smith & Nephew PLC

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat